Reduction of Temporomandibular Joint Pain after Treatment with a Combination of Methotrexate and Infliximab Is Associated with Changes in Synovial Fluid and Plasma Cytokines in Rheumatoid Arthritis

Publisher： Karger

E-ISSN： 1422-6421|180|1|22-30

ISSN： 1422-6405

Source： Cells Tissues Organs, Vol.180, Iss.1, 2005-07, pp. : 22-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-cytokines and Cytokines in the Treatment of Rheumatoid Arthritis

By  

Current Pharmaceutical Design, Vol. 9, Iss. 14, 2003-01 ,pp. : 1095-1126

Bentham Science Publishers

Access to resources Recommend Favorite

Benefit-Risk Assessment of Infliximab in the Treatment of Rheumatoid Arthritis

By Mikuls T.R.  

Drug Safety, Vol. 26, Iss. 1, 2003-01 ,pp. : 23-32

Adis International

Access to resources Recommend Favorite

The Role of Synovial Fibroblasts in Mediating Joint Destruction in Rheumatoid Arthritis

By  

Current Pharmaceutical Design, Vol. 11, Iss. 5, 2005-02 ,pp. : 563-568

Bentham Science Publishers

Access to resources Recommend Favorite

Early changes in bone metabolism in rheumatoid arthritis patients treated with infliximab

By  

Arthritis & Rheumatism, Vol. 48, Iss. 10, 2003-10 ,pp. : 2996-2997

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cyclosporine a Pharmacokinetics in Rheumatoid Arthritis Patients After 6 Months of Methotrexate Therapy

By Baraldo M.   Ferraccioli G.   Pea F.   Gremese E.   Furlanut M.  

Pharmacological Research, Vol. 40, Iss. 6, 1999-12 ,pp. : 483-486

Academic Press

Access to resources Recommend Favorite